PRDX6 and bladder transitional cell carcinoma: Finally, PRDX6, which had 13% genetic alterations and correlations with CNV, methylation was 0.61 (P < 0.01) and -0.32 (P < 0.01), was selected to explore the functions of PRDXs in BLCA.